Form 4/A for BBIO BridgeBio Pharma, Inc.
Accepted 2025-06-30 00:00:00 ET · period of report 2021-12-28 · accession 0000950170-25-091756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-06-30 | 2021-12-28 | BBIO | Valantine Hannah | Dir | P - Purchase | $12.68 | +1,542 | 1,542 | New | +$19.6K |
| AI | 2025-06-30 | 2021-12-28 | BBIO | Valantine Hannah | Dir | P - Purchase | $13.16 | +796 | 2,687 | +42% | +$10.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-28 | P | A | 1,542 | $12.68 | 1,542 | D By Spouse | — | — | |
| 2 | Common | Common Stock | 2021-12-28 | P | A | 796 | $13.16 | 2,687 | I | — | — |